Lilly claims another victory in Alimta patent defence

Lilly claims another victory in Alimta patent defence

Source: 
Pharmaforum
snippet: 

Eli Lilly ended 2019 with a win in its long-running legal battle to prevent generics of its big-selling cancer drug Alimta from reaching the US market.